A new meta-analysis, published in Frontiers in Cardiovascular Medicine, focused on data from nearly 3,000 patients with severe symptomatic aortic stenosis.

Dense calcifications have long been viewed as one of the most challenging aspects of TLE procedures. IVL may offer specialists a new way to address that issue. 

“Our pricing strategy for Lodoco is focused on helping to ensure access to as many people as possible,” an executive with Agepha Pharma told Cardiovascular Business. 

The FDA has said this is a Class I recall, which means using the devices “may cause serious injuries or death.” A total of 18 injuries have been reported so far. 

"The FDA's approval of colchicine confirms that we are entering a new era of patient care," said one veteran cardiologist familiar with the drug. 

The three-year grant will help the ADA fund two pilot programs and engage with healthcare professionals and other industry leaders.

When patients wear VR glasses during transcatheter aortic valve replacement, they say it helps time go by more quickly and reduces anxiety.

Attaching ECG sensors to the handles of shopping carts could help identify signs of atrial fibrillation in patients who don't even realize they have it.